☰

Aram S. Modrek - Publications

Affiliations: 
2012-2016 New York University School of Medicine, New York, NY, United States 
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Modrek AS, Eskilsson E, Ezhilarasan R, Wang Q, Goodman LD, Ding Y, Zhang ZY, Bhat KPL, Le TT, Barthel FP, Tang M, Yang J, Long L, Gumin J, Lang FF, et al. PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Frontiers in Oncology. 12: 941657. PMID 36059614 DOI: 10.3389/fonc.2022.941657  0.317
2021 Modrek AS, Tanese N, Placantonakis DG, Sulman EP, Rivera R, Du KL, Gerber NK, David G, Chesler M, Philips MR, Cangiarella J. Breaking Tradition to Bridge Bench and Bedside: Accelerating the MD-PhD-Residency Pathway. Academic Medicine : Journal of the Association of American Medical Colleges. PMID 33464738 DOI: 10.1097/ACM.0000000000003920  0.469
2019 Golub D, Iyengar N, Dogra S, Wong T, Bready D, Tang K, Modrek AS, Placantonakis DG. Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics. Frontiers in Oncology. 9: 417. PMID 31165048 DOI: 10.3389/Fonc.2019.00417  0.757
2019 Bready D, Modrek A, Guerrera A, Frenster J, Skok J, Placantonakis D. STEM-17. LOW GRADE ASTROCYTOMA MUTATIONS COOPERATE TO DISRUPT SOX2 GENOMIC ARCHITECTURE AND BLOCK DIFFERENTIATION VIA PREVIOUSLY UNIDENTIFIED ENHANCER ELEMENTS Neuro-Oncology. 21: vi237-vi237. DOI: 10.1093/Neuonc/Noz175.990  0.701
2018 Stafford JM, Lee CH, Voigt P, Descostes N, Saldaña-Meyer R, Yu JR, Leroy G, Oksuz O, Chapman JR, Suarez F, Modrek AS, Bayin NS, Placantonakis DG, Karajannis MA, Snuderl M, et al. Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma. Science Advances. 4: eaau5935. PMID 30402543 DOI: 10.1126/Sciadv.Aau5935  0.734
2018 Modrek AS, Prado J, Bready D, Dhaliwal J, Golub D, Placantonakis DG. Modeling Glioma with Human Embryonic Stem Cell-Derived Neural Lineages. Methods in Molecular Biology (Clifton, N.J.). 1741: 227-237. PMID 29392705 DOI: 10.1007/978-1-4939-7659-1_19  0.784
2017 Modrek AS, Golub D, Khan T, Bready D, Prado J, Bowman C, Deng J, Zhang G, Rocha PP, Raviram R, Lazaris C, Stafford JM, LeRoy G, Kader M, Dhaliwal J, et al. Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2. Cell Reports. 21: 1267-1280. PMID 29091765 DOI: 10.1016/J.Celrep.2017.10.009  0.722
2017 Bayin NS, Frenster JD, Sen R, Si S, Modrek AS, Galifianakis N, Dolgalev I, Ortenzi V, Illa-Bochaca I, Khahera A, Serrano J, Chiriboga L, Zagzag D, Golfinos JG, Doyle W, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. 8: 64932-64953. PMID 29029402 DOI: 10.18632/Oncotarget.18117  0.775
2017 Pourchet A, Modrek AS, Placantonakis DG, Mohr I, Wilson AC. Modeling HSV-1 Latency in Human Embryonic Stem Cell-Derived Neurons. Pathogens (Basel, Switzerland). 6. PMID 28594343 DOI: 10.3390/Pathogens6020024  0.596
2017 Bayin NS, Frenster JD, Sen R, Si S, Modrek AS, Galifianakis N, Dolgalev I, Ortenzi V, Illa-Bochaca I, Khahera A, Serrano J, Chiriboga L, Zagzag D, Golfinos JG, Doyle W, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. PMID 28586758 DOI: 10.18632/oncotarget.18117  0.79
2017 Kader M, Frenster J, Liechty B, Modrek A, Tsirigos A, Golfinos J, Eisele S, Jain R, Shepherd T, Fatterpekar G, MacNeil D, Shohdy N, Huang X, Chi AS, Snuderl M, et al. CBIO-19. CHARACTERIZATION OF GPR133 EXPRESSION IN GLIOMA SUBTYPES Neuro-Oncology. 19: vi36-vi36. DOI: 10.1093/Neuonc/Nox168.138  0.57
2017 Modrek A, Golub D, Khan T, Prado J, Bowman C, Deng J, Zhang G, Rocha P, Raviram R, Lazaris H, Kader M, Dhaliwal J, Chi A, Golfinos J, Tsirigos A, et al. LGG-11. LOW-GRADE ASTROCYTOMA CORE MUTATIONS IN IDH1, P53 AND ATRX COOPERATE TO BLOCK DIFFERENTIATION OF HUMAN NEURAL STEM CELLS VIA EPIGENETIC REPRESSION OF SOX2 Neuro-Oncology. 19: iv35-iv35. DOI: 10.1093/Neuonc/Nox083.144  0.677
2016 Bayin NS, Frenster JD, Kane JR, Rubenstein J, Modrek AS, Baitalmal R, Dolgalev I, Rudzenski K, Scarabottolo L, Crespi D, Redaelli L, Snuderl M, Golfinos JG, Doyle W, Pacione D, et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis. 5: e263. PMID 27775701 DOI: 10.1038/oncsis.2016.63  0.788
2016 Tyagi V, Theobald J, Barger J, Bustoros M, Bayin NS, Modrek AS, Kader M, Anderer EG, Donahue B, Fatterpekar G, Placantonakis DG. Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports. Surgical Neurology International. 7: 78. PMID 27625888 DOI: 10.4103/2152-7806.189296  0.7
2016 Bustoros M, Thomas C, Frenster J, Modrek AS, Bayin NS, Snuderl M, Rosen G, Schiff PB, Placantonakis DG. Adult Primary Spinal Epidural Extraosseous Ewing's Sarcoma: A Case Report and Review of the Literature. Case Reports in Neurological Medicine. 2016: 1217428. PMID 27610254 DOI: 10.1155/2016/1217428  0.708
2016 Bayin NS, Frenster J, Kane JR, Modrek A, Shohdy N, MacNeil DJ, Zagzag D, Placantonakis DG. 144 GPR133 Promotes Glioblastoma Growth in Hypoxia. Neurosurgery. 63: 158-159. PMID 27399423 DOI: 10.1227/01.neu.0000489714.29455.e6  0.77
2016 Frenster J, Bayin NS, Kane JR, Rubenstein J, Modrek A, Baitamal R, Dolgalev I, Rudzenski K, Snuderl M, Golfinos J, Doyle W, Pacione D, Chi A, Heguy A, Shohdy N, et al. STMC-25. GPR133 PROMOTES HYPOXIA-DRIVEN TUMOR PROGRESSION IN GLIOBLASTOMA Neuro-Oncology. 18: vi187-vi188. DOI: 10.1093/Neuonc/Now212.788  0.766
2016 Modrek A, Golub D, Khan T, Zhang G, Kader M, Bowman C, Prado J, Bayin NS, Frenster J, Lhakhang T, Heguy A, Dankert J, Tsirigos A, Snuderl M, Neubert T, et al. STMC-21. ASTROCYTOMA MUTATIONS IDH1, p53 AND ATRX COOPERATE TO BLOCK DIFFERENTIATION OF NEURAL STEM CELLS VIA Sox2 Neuro-Oncology. 18: vi187-vi187. DOI: 10.1093/Neuonc/Now212.784  0.779
2015 Modrek A, Khan T, Kader M, Bayin S, Zhang G, Neubert T, Placantonakis D. TMOD-06TUMORIGENIC ALTERATIONS BY MUTANT IDH1 IN EARLY GLIOMAGENESIS Neuro-Oncology. 17: v227.2-v227. DOI: 10.1093/Neuonc/Nov237.06  0.555
2015 Bayin NS, Kane JR, Modrek AS, Shohdy N, MacNeil D, Zagzag D, Placantonakis DG. STEM-05GPR133 IS ENRICHED IN GLIOBLASTOMA STEM CELLS AND REGULATES THE RESPONSE TO HYPOXIA Neuro-Oncology. 17: v209.1-v209. DOI: 10.1093/Neuonc/Nov234.05  0.786
2015 Bayin NS, Sen R, Si S, Modrek AS, Ortenzi V, Zagzag D, Snuderl M, Golfinos JG, Doyle W, Galifianakis N, Chesler M, Illa-Bochaca I, Barcellos-Hoff MH, Dolgalev I, Heguy A, et al. STEM-04DEFINING GLIOBLASTOMA STEM CELL HETEROGENEITY Neuro-Oncology. 17: v208.4-v209. DOI: 10.1093/Neuonc/Nov234.04  0.803
2014 Bayin NS, Modrek AS, Dietrich A, Lebowitz J, Abel T, Song HR, Schober M, Zagzag D, Buchholz CJ, Chao MV, Placantonakis DG. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells. Plos One. 9: e116114. PMID 25541984 DOI: 10.1371/Journal.Pone.0116114  0.765
2014 Bayin NS, Modrek AS, Placantonakis DG. Glioblastoma stem cells: Molecular characteristics and therapeutic implications. World Journal of Stem Cells. 6: 230-8. PMID 24772249 DOI: 10.4252/Wjsc.V6.I2.230  0.799
2014 Modrek AS, Bayin NS, Placantonakis DG. Brain stem cells as the cell of origin in glioma. World Journal of Stem Cells. 6: 43-52. PMID 24567787 DOI: 10.4252/Wjsc.V6.I1.43  0.794
2014 Sumru Bayin N, Si S, Modrek A, Song H, Zagzag D, Hoang DM, Wadghiri YZ, Dolgalev I, Baysan M, Heguy A, Barcellos-Hoff MH, Placantonakis D. SC-04 * NON-UNIFORM NOTCH SIGNALING UNDERLIES HETEROGENEITY WITHIN THE GLIOBLASTOMA STEM CELL POPULATION Neuro-Oncology. 16: v197-v197. DOI: 10.1093/Neuonc/Nou275.4  0.681
Show low-probability matches.